- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02357381
eNeura SpringTMS Post-Market Observational US Study of Migraine (ESPOUSE)
eNeura SpringTMS Post-Market Observational U.S. Study of Migraine
Study Overview
Detailed Description
A prospective, non-randomized, single arm, multi-center observational study designed to evaluate the use of the SpringTMS system in reducing the frequency of headache days.
Note: This is a NON-SIGNIFICANT RISK (NSR) study of a NON-SIGNIFICANT RISK (NSR) Device. It is a post market study of a NSR device cleared by FDA through the 510(k) pre-market notification process. The cleared indications for use are provided above. This NSR study is designed to collect information on additional applications of the SpringTMS device. These additional applications include:
- Use of the device to evaluate the potential for regular use of sTMS to reduce the frequency, severity, and/or duration of migraine.
- Delivery of additional treatments (pulses) to evaluate the acute treatment efficacy of breakthrough migraine attacks with and without aura.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Arizona
-
Phoenix, Arizona, United States, 85054
- Mayo Clinic
-
-
California
-
Los Angeles, California, United States, 90095
- UCLA Headache Research and Treatment Program
-
Stanford, California, United States, 94563
- Stanford Headache Program
-
-
Maryland
-
Rockville, Maryland, United States, 20852
- Mid Atlantic Permanente Medical Group-Kaiser
-
-
New York
-
Bronx, New York, United States, 10461
- Albert Einstein College of Medicine
-
-
Ohio
-
Cleveland, Ohio, United States, 44106
- The Cleveland Clinic Center for Headache and Pain
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19107
- Jefferson Headache Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients 18 to 65 years of age;
- Patients able to understand and communicate in English;
- Migraine with or without aura;
- 4-25 headache days per month (confirmed by 1-month baseline diary, minimum of 5 complete headache-free days/month);
- Understand and willing to provide diary and survey data.
Exclusion Criteria:
Subjects will be excluded from participating in this trial if they meet any of the following criteria
- Severe co-existing disease having a life expectancy of less than 1 year;
- Currently involved in any other investigational clinical trials that have not completed their primary endpoint or that may interfere with the SpringTMS study results;
- Mental impairment or other conditions which may not allow the subject to understand the nature, significance and scope of the study and to cooperate with follow-up requirements;
- Known drug and/or alcohol addiction or use of illicit substances;
- Patients with epilepsy or history of seizure;
- Severe active major depression or major psychiatric illness;
- Concurrent use of other neurostimulation devices (Cefaly®, TENS, implantable devices);
- Use of Botox® within past 4 months;
- Extracranial nerve block (e.g. occipital, supraorbital) within past 3 months;
- Use of Cefaly for prevention within past month;
- Patients with metal containing implants as follows:
The SpringTMS may not be used in patients who have metals, conductive materials, or metal-containing implants in their head, neck or upper body. Patients with implants that are affected by a magnetic field should not use the SpringTMS. Examples of such implants include:
- Aneurysm clips or coils • Radioactive seeds
- Cochlear implants • Magnetically programmable shunt valves
- Cerebral spinal fluid shunts • Stents
- Bullets or pellets lodged in the head or upper body • Metal plates, screws, staples or sutures in skull, neck, shoulders, arms or hands
- Filters • Metallic artificial heart valves
- Electrodes • Facial tattoos with metallic ink Dental implants, fillings, or other dental appliances are okay and are not affected by the device.
Note: although not explicitly excluded, safety and effectiveness have not been established in pregnant women. Please defer to the judgment of the investigator when considering the eligibility of this population.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
TMS Treatment
TMS( transcranial magnetic stimulation) -treatment for headache
|
Single pulse magnetic stimulation for prevention and/or treatment of migraine headache with or without aura.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Headache Days
Time Frame: 3 months
|
Reduction in mean headache days
|
3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: David W Dodick, MD, Mayo Clinic , Phoenix,AZ
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SpringTMSUSPMOS 2014-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Headache
-
University GhentRecruitingTension-Type Headache | Cervicogenic Headache | Myofascial HeadacheBelgium
-
Canadian Memorial Chiropractic CollegeDr. Zaxx Co.UnknownMigraine Headache | Cervicogenic Headache | Tension-type HeadacheCanada
-
Real Centro Universitario Maria CristinaRecruiting
-
Uniformed Services University of the Health SciencesNational Institutes of Health (NIH); University of North Carolina, Chapel Hill and other collaboratorsRecruitingPost-Traumatic Headache Chronic Without Intractable HeadacheUnited States
-
Brooke Army Medical CenterThe University of Queensland; The Defense and Veterans Brain Injury CenterRecruitingHeadache, Migraine | Persistent Post Traumatic Headache | Cervicogenic HeadacheUnited States
-
University Hospital, GhentCompletedMigraine Disorders | Headache Disorders | Tension-Type Headache | Cluster Headache | TACS | Secondary Headache DisorderBelgium
-
University of WashingtonTerminatedChronic Post Traumatic HeadacheUnited States
-
Bnai Zion Medical CenterUnknownChildren, Only | Headache, Migraine | Headache, TensionIsrael
-
University of California, Los AngelesTerminatedChronic Daily Headache | Post Traumatic HeadacheUnited States
-
University of AlbertaCompletedChronic Headache | Chronic Daily Headache | Analgesic Rebound Headache | Headache, IntractableCanada